SCHEMBL28435235

SCHEMBL28435235

CCN1CCN(C(=O)N[C@@H](C(=O)Cl)c2ccc(O)cc2)C(=O)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ SLC22A6 Q4U2R8 1/20 0.43
▸ SLC22A8 Q8TCC7 1/20 0.43
▸ SLC22A11 Q9NSA0 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ POLB P06746 2/20 0.37
▸ GAA P10253 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ FOLH1 Q04609 1/20 0.33
▸ UGCG Q16739 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ NAALAD2 Q9Y3Q0 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28473803 1.00 MAPT (0.43) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL9327248 0.89 MAPT (0.46) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL10543158 0.89 POLB (0.40) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL11431737 0.89 MAPT (0.46) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL8600205 0.89 POLB (0.40) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL9567734 0.89 MAPT (0.46) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL14288987 0.89 MAPT (0.44) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL8113253 0.88 MAPT (0.43) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL3731768 0.88 MAPT (0.43) MAPTPDE3ASLC22A6SLC22A8SLC22A11
SCHEMBL3731770 0.88 MAPT (0.43) MAPTPDE3ASLC22A6SLC22A8SLC22A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110393719-B Cefoperazone sodium and sulbactam sodium composition pharmaceutical preparation and new indications for treating infectious endocarditis 广东金城金素制药有限公司 2021-09-28 — — CN claimed
CN-111499658-B Cefoperazone compound medicinal preparation and new indication for treating endometritis and other gynecological genital tract infection 广东金城金素制药有限公司 2021-05-18 — — CN claimed
CN-111499658-A New indications of cefoperazone medicinal preparation for treating endometritis and other gynecological genital tract infections 广东赛法洛药业有限公司 2020-08-07 — — CN claimed
CN-110393719-B Cefoperazone sodium and sulbactam sodium composition pharmaceutical preparation and new indications for treating infectious endocarditis 广东金城金素制药有限公司 2021-09-28 — — CN disclosed
CN-111499658-B Cefoperazone compound medicinal preparation and new indication for treating endometritis and other gynecological genital tract infection 广东金城金素制药有限公司 2021-05-18 — — CN disclosed
CN-111499658-A New indications of cefoperazone medicinal preparation for treating endometritis and other gynecological genital tract infections 广东赛法洛药业有限公司 2020-08-07 — — CN disclosed
Send feedback